Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms, Hereditary Nonpolyposis | 23 | 2024 | 380 | 4.230 |
Why?
|
Colonic Neoplasms | 33 | 2020 | 2522 | 3.590 |
Why?
|
Adenomatous Polyposis Coli | 14 | 2022 | 218 | 3.340 |
Why?
|
Adenoma | 19 | 2023 | 2147 | 2.800 |
Why?
|
Colorectal Neoplasms | 35 | 2024 | 6840 | 2.380 |
Why?
|
Stomach Neoplasms | 14 | 2024 | 1422 | 2.110 |
Why?
|
Retinal Dystrophies | 6 | 2022 | 64 | 1.830 |
Why?
|
Microsatellite Instability | 12 | 2019 | 715 | 1.800 |
Why?
|
Genetic Testing | 17 | 2024 | 3529 | 1.740 |
Why?
|
cis-trans-Isomerases | 12 | 2022 | 44 | 1.580 |
Why?
|
DNA Mismatch Repair | 8 | 2024 | 428 | 1.490 |
Why?
|
Colonoscopy | 17 | 2024 | 1385 | 1.310 |
Why?
|
Gene Expression Regulation, Neoplastic | 20 | 2019 | 8503 | 1.310 |
Why?
|
Neoplastic Syndromes, Hereditary | 7 | 2019 | 243 | 1.280 |
Why?
|
Early Detection of Cancer | 11 | 2024 | 3164 | 1.270 |
Why?
|
Colonic Polyps | 8 | 2023 | 550 | 1.270 |
Why?
|
Precancerous Conditions | 4 | 2024 | 977 | 1.180 |
Why?
|
Germ-Line Mutation | 11 | 2024 | 1841 | 1.100 |
Why?
|
Feces | 8 | 2024 | 1455 | 1.070 |
Why?
|
ras Proteins | 5 | 2014 | 1050 | 0.970 |
Why?
|
Pancreatic Neoplasms | 20 | 2024 | 5348 | 0.950 |
Why?
|
Carcinoma, Signet Ring Cell | 2 | 2019 | 82 | 0.920 |
Why?
|
DNA, Neoplasm | 4 | 2024 | 1745 | 0.920 |
Why?
|
Adenomatous Polyps | 3 | 2014 | 108 | 0.840 |
Why?
|
Pupil | 3 | 2013 | 143 | 0.810 |
Why?
|
Neuroendocrine Tumors | 7 | 2017 | 641 | 0.800 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2016 | 1135 | 0.790 |
Why?
|
Carcinoid Tumor | 3 | 2015 | 224 | 0.790 |
Why?
|
Mass Screening | 8 | 2024 | 5412 | 0.780 |
Why?
|
Intestinal Neoplasms | 6 | 2017 | 311 | 0.780 |
Why?
|
Neovascularization, Pathologic | 11 | 2010 | 2638 | 0.770 |
Why?
|
Genes, ras | 5 | 2010 | 654 | 0.730 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 6 | 2010 | 611 | 0.730 |
Why?
|
Proto-Oncogene Proteins | 9 | 2019 | 4492 | 0.720 |
Why?
|
Choroideremia | 5 | 2022 | 27 | 0.680 |
Why?
|
Adenocarcinoma | 13 | 2024 | 6323 | 0.650 |
Why?
|
Genetic Vectors | 16 | 2022 | 3379 | 0.650 |
Why?
|
Leber Congenital Amaurosis | 4 | 2016 | 36 | 0.650 |
Why?
|
Cadherins | 7 | 2024 | 897 | 0.640 |
Why?
|
Dependovirus | 12 | 2022 | 711 | 0.640 |
Why?
|
Eye Diseases, Hereditary | 2 | 2018 | 118 | 0.630 |
Why?
|
Cell Hypoxia | 5 | 2013 | 656 | 0.620 |
Why?
|
Proto-Oncogene Proteins B-raf | 5 | 2017 | 2052 | 0.590 |
Why?
|
Carcinoma, Papillary | 3 | 2007 | 784 | 0.580 |
Why?
|
Gastritis | 1 | 2019 | 199 | 0.570 |
Why?
|
Cyclin D1 | 3 | 2005 | 451 | 0.570 |
Why?
|
Cysts | 1 | 2022 | 681 | 0.560 |
Why?
|
Mutation | 30 | 2021 | 29929 | 0.560 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2016 | 989 | 0.550 |
Why?
|
Fluorouracil | 6 | 2018 | 1636 | 0.550 |
Why?
|
Visually Impaired Persons | 1 | 2017 | 78 | 0.550 |
Why?
|
Visual Acuity | 8 | 2021 | 2642 | 0.540 |
Why?
|
Carcinoma, Pancreatic Ductal | 4 | 2022 | 1723 | 0.540 |
Why?
|
Gene Transfer Techniques | 5 | 2015 | 1203 | 0.540 |
Why?
|
Visual Fields | 5 | 2021 | 1054 | 0.530 |
Why?
|
Eye Proteins | 6 | 2011 | 633 | 0.530 |
Why?
|
Helicobacter Infections | 1 | 2019 | 385 | 0.510 |
Why?
|
Retinal Diseases | 1 | 2021 | 702 | 0.500 |
Why?
|
Gastrointestinal Hemorrhage | 6 | 2016 | 1111 | 0.500 |
Why?
|
Immunohistochemistry | 15 | 2024 | 11063 | 0.490 |
Why?
|
Common Bile Duct Neoplasms | 2 | 2014 | 120 | 0.490 |
Why?
|
Ampulla of Vater | 2 | 2014 | 149 | 0.490 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2016 | 642 | 0.480 |
Why?
|
Genetic Counseling | 7 | 2024 | 624 | 0.480 |
Why?
|
Humans | 189 | 2024 | 757566 | 0.480 |
Why?
|
Carrier Proteins | 14 | 2015 | 4937 | 0.480 |
Why?
|
Gastrointestinal Neoplasms | 5 | 2008 | 951 | 0.480 |
Why?
|
Cecal Neoplasms | 1 | 2014 | 26 | 0.470 |
Why?
|
Adrenomedullin | 1 | 2013 | 85 | 0.450 |
Why?
|
Chitosan | 1 | 2015 | 130 | 0.440 |
Why?
|
Endoscopy, Digestive System | 2 | 2014 | 351 | 0.440 |
Why?
|
Rectal Neoplasms | 8 | 2011 | 1154 | 0.440 |
Why?
|
Vascular Endothelial Growth Factor A | 13 | 2010 | 3480 | 0.430 |
Why?
|
MutS Homolog 2 Protein | 4 | 2019 | 195 | 0.430 |
Why?
|
Reflex, Pupillary | 2 | 2012 | 59 | 0.420 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2015 | 435 | 0.420 |
Why?
|
Genes, Tumor Suppressor | 7 | 2013 | 1055 | 0.420 |
Why?
|
Hypoxia-Inducible Factor 1 | 3 | 2009 | 193 | 0.410 |
Why?
|
Integrases | 1 | 2015 | 516 | 0.410 |
Why?
|
Loss of Heterozygosity | 8 | 2010 | 659 | 0.400 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2012 | 161 | 0.390 |
Why?
|
Promoter Regions, Genetic | 13 | 2017 | 5778 | 0.390 |
Why?
|
Chromosomal Instability | 2 | 2010 | 178 | 0.390 |
Why?
|
DNA Glycosylases | 3 | 2011 | 124 | 0.380 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2013 | 2823 | 0.370 |
Why?
|
Endometrial Neoplasms | 2 | 2018 | 1356 | 0.370 |
Why?
|
Cyclins | 6 | 2013 | 593 | 0.360 |
Why?
|
CD-ROM | 1 | 2010 | 24 | 0.360 |
Why?
|
Plasmids | 2 | 2015 | 2275 | 0.350 |
Why?
|
Blindness | 5 | 2016 | 582 | 0.350 |
Why?
|
DNA Methylation | 5 | 2019 | 4372 | 0.340 |
Why?
|
Optic Neuritis | 1 | 2012 | 174 | 0.340 |
Why?
|
Thyroid Neoplasms | 3 | 2007 | 2326 | 0.330 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 6 | 2014 | 1728 | 0.330 |
Why?
|
Male | 94 | 2024 | 358180 | 0.330 |
Why?
|
DNA-Binding Proteins | 11 | 2019 | 9574 | 0.330 |
Why?
|
Adult | 71 | 2024 | 219725 | 0.330 |
Why?
|
Middle Aged | 70 | 2024 | 219192 | 0.320 |
Why?
|
Female | 97 | 2024 | 389943 | 0.320 |
Why?
|
Optic Nerve | 1 | 2012 | 567 | 0.310 |
Why?
|
Adaptor Proteins, Signal Transducing | 5 | 2014 | 2891 | 0.310 |
Why?
|
Diverticulum | 2 | 2020 | 137 | 0.300 |
Why?
|
Genetic Markers | 6 | 2014 | 2608 | 0.290 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2008 | 285 | 0.290 |
Why?
|
Aged | 56 | 2024 | 167890 | 0.280 |
Why?
|
Tumor Microenvironment | 3 | 2020 | 3839 | 0.280 |
Why?
|
Light | 2 | 2012 | 1344 | 0.280 |
Why?
|
Colon | 4 | 2016 | 1788 | 0.280 |
Why?
|
Base Pair Mismatch | 3 | 2005 | 92 | 0.280 |
Why?
|
Hyperplasia | 3 | 2022 | 1153 | 0.280 |
Why?
|
Wnt Proteins | 3 | 2005 | 719 | 0.280 |
Why?
|
Mesoderm | 1 | 2009 | 672 | 0.270 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2012 | 822 | 0.270 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2014 | 2859 | 0.260 |
Why?
|
Genes, APC | 2 | 2003 | 145 | 0.260 |
Why?
|
Aged, 80 and over | 28 | 2024 | 58558 | 0.260 |
Why?
|
Nuclear Proteins | 4 | 2014 | 5786 | 0.250 |
Why?
|
Occult Blood | 2 | 2024 | 197 | 0.250 |
Why?
|
Gastrectomy | 4 | 2019 | 669 | 0.250 |
Why?
|
Parathyroid Neoplasms | 2 | 2004 | 241 | 0.250 |
Why?
|
Retinal Degeneration | 1 | 2009 | 412 | 0.250 |
Why?
|
Patient Compliance | 2 | 2015 | 2685 | 0.240 |
Why?
|
Homeodomain Proteins | 4 | 2019 | 2412 | 0.240 |
Why?
|
Gastroscopy | 2 | 2019 | 210 | 0.240 |
Why?
|
Islets of Langerhans | 3 | 2005 | 1345 | 0.240 |
Why?
|
Genetic Association Studies | 4 | 2019 | 2717 | 0.240 |
Why?
|
Cell Line, Tumor | 13 | 2014 | 16881 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 11 | 2024 | 17767 | 0.240 |
Why?
|
Retina | 9 | 2022 | 2637 | 0.240 |
Why?
|
Thrombospondin 1 | 1 | 2005 | 257 | 0.230 |
Why?
|
Phosphoproteins | 6 | 2013 | 2432 | 0.230 |
Why?
|
Eye Diseases | 1 | 2009 | 651 | 0.230 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2007 | 323 | 0.230 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2005 | 407 | 0.220 |
Why?
|
DNA Repair Enzymes | 2 | 2016 | 344 | 0.210 |
Why?
|
Stomach | 1 | 2007 | 694 | 0.210 |
Why?
|
Signal Transduction | 13 | 2021 | 23335 | 0.200 |
Why?
|
Carcinoma | 4 | 2020 | 2330 | 0.200 |
Why?
|
Interleukin-8 | 1 | 2005 | 696 | 0.200 |
Why?
|
Transfection | 6 | 2016 | 5777 | 0.200 |
Why?
|
DNA Repair | 3 | 2003 | 2038 | 0.200 |
Why?
|
Heterozygote | 8 | 2024 | 2797 | 0.200 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2022 | 100 | 0.200 |
Why?
|
Cell Proliferation | 7 | 2012 | 10405 | 0.190 |
Why?
|
Electroretinography | 4 | 2018 | 517 | 0.190 |
Why?
|
Sensitivity and Specificity | 4 | 2024 | 14637 | 0.190 |
Why?
|
Epithelial Cells | 4 | 2010 | 3664 | 0.190 |
Why?
|
Gene Expression Regulation | 5 | 2015 | 11890 | 0.190 |
Why?
|
Transcription Factors | 7 | 2021 | 12092 | 0.190 |
Why?
|
Duodenal Neoplasms | 2 | 2014 | 115 | 0.190 |
Why?
|
Mice, Nude | 5 | 2013 | 3600 | 0.190 |
Why?
|
Antigens, CD | 6 | 2024 | 3996 | 0.190 |
Why?
|
Polyendocrinopathies, Autoimmune | 1 | 2021 | 55 | 0.180 |
Why?
|
Retinal Perforations | 1 | 2022 | 138 | 0.180 |
Why?
|
Adenosine Triphosphatases | 2 | 2016 | 831 | 0.180 |
Why?
|
Injections, Intraocular | 3 | 2021 | 33 | 0.180 |
Why?
|
Vision, Ocular | 3 | 2022 | 454 | 0.180 |
Why?
|
Adolescent | 28 | 2021 | 87819 | 0.180 |
Why?
|
Genotype | 8 | 2015 | 12951 | 0.170 |
Why?
|
Thyroid Gland | 1 | 2006 | 1167 | 0.170 |
Why?
|
Eye | 3 | 2015 | 710 | 0.170 |
Why?
|
Patient Education as Topic | 1 | 2010 | 2306 | 0.170 |
Why?
|
Visual Field Tests | 2 | 2019 | 411 | 0.170 |
Why?
|
Gastrins | 2 | 1998 | 74 | 0.170 |
Why?
|
Retrospective Studies | 13 | 2024 | 79984 | 0.160 |
Why?
|
Endothelial Growth Factors | 1 | 2001 | 672 | 0.160 |
Why?
|
Retinal Cone Photoreceptor Cells | 3 | 2016 | 180 | 0.160 |
Why?
|
Chromosome Mapping | 4 | 2007 | 4624 | 0.150 |
Why?
|
Endosonography | 1 | 2022 | 607 | 0.150 |
Why?
|
Colitis, Microscopic | 1 | 2019 | 72 | 0.150 |
Why?
|
Lymphokines | 1 | 2001 | 926 | 0.150 |
Why?
|
Codon, Nonsense | 2 | 2014 | 281 | 0.150 |
Why?
|
Animals | 38 | 2024 | 167718 | 0.150 |
Why?
|
Chromosomes, Human, Pair 18 | 5 | 2007 | 246 | 0.150 |
Why?
|
Adenoma, Islet Cell | 1 | 1997 | 72 | 0.150 |
Why?
|
Glycine | 1 | 2021 | 662 | 0.150 |
Why?
|
Up-Regulation | 5 | 2010 | 4110 | 0.150 |
Why?
|
Aspirin | 3 | 2020 | 3128 | 0.150 |
Why?
|
Angiogenesis Inhibitors | 4 | 2009 | 2047 | 0.150 |
Why?
|
Genes, Retinoblastoma | 1 | 1997 | 125 | 0.150 |
Why?
|
Peutz-Jeghers Syndrome | 2 | 2011 | 59 | 0.140 |
Why?
|
Electronic Health Records | 1 | 2015 | 4760 | 0.140 |
Why?
|
Dinoprostone | 1 | 2020 | 598 | 0.140 |
Why?
|
Tomography, Optical Coherence | 4 | 2022 | 2880 | 0.140 |
Why?
|
Young Adult | 14 | 2022 | 58755 | 0.140 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2010 | 614 | 0.140 |
Why?
|
Probiotics | 1 | 2021 | 377 | 0.140 |
Why?
|
Intestine, Small | 3 | 2017 | 1205 | 0.140 |
Why?
|
Caco-2 Cells | 3 | 2010 | 364 | 0.140 |
Why?
|
Scleroderma, Systemic | 1 | 2021 | 344 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2014 | 9245 | 0.140 |
Why?
|
Vision Tests | 1 | 2017 | 158 | 0.140 |
Why?
|
Syndrome | 4 | 2007 | 3261 | 0.140 |
Why?
|
Retinal Neurons | 1 | 2016 | 66 | 0.140 |
Why?
|
Gene Expression Profiling | 4 | 2009 | 9403 | 0.130 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 1997 | 315 | 0.130 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2010 | 606 | 0.130 |
Why?
|
Algorithms | 4 | 2013 | 13952 | 0.130 |
Why?
|
Neoplasm Proteins | 4 | 2016 | 3608 | 0.130 |
Why?
|
Time Factors | 11 | 2021 | 39811 | 0.130 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2014 | 1888 | 0.130 |
Why?
|
Alternative Splicing | 1 | 2021 | 1091 | 0.130 |
Why?
|
Colectomy | 3 | 2020 | 687 | 0.130 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2021 | 892 | 0.130 |
Why?
|
Pedigree | 7 | 2016 | 4578 | 0.130 |
Why?
|
Ligases | 1 | 1997 | 332 | 0.130 |
Why?
|
Inhibitory Concentration 50 | 1 | 2016 | 462 | 0.130 |
Why?
|
DNA Repair-Deficiency Disorders | 1 | 2016 | 37 | 0.130 |
Why?
|
Gene Deletion | 3 | 1998 | 2666 | 0.130 |
Why?
|
Colonic Diseases | 1 | 2017 | 201 | 0.130 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2009 | 4565 | 0.130 |
Why?
|
Transgenes | 3 | 2015 | 1007 | 0.130 |
Why?
|
HCT116 Cells | 1 | 2016 | 402 | 0.130 |
Why?
|
Mice | 26 | 2024 | 81066 | 0.130 |
Why?
|
Cyclooxygenase 2 Inhibitors | 2 | 2009 | 320 | 0.130 |
Why?
|
Smad2 Protein | 2 | 2009 | 145 | 0.130 |
Why?
|
Tumor Cells, Cultured | 4 | 2008 | 6128 | 0.130 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2013 | 3774 | 0.130 |
Why?
|
Ventricular Function | 1 | 1997 | 406 | 0.130 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 249 | 0.120 |
Why?
|
Zebrafish Proteins | 1 | 2001 | 1006 | 0.120 |
Why?
|
Age of Onset | 3 | 2018 | 3296 | 0.120 |
Why?
|
Decision Support Techniques | 2 | 2024 | 1991 | 0.120 |
Why?
|
Vegetables | 1 | 2020 | 1194 | 0.120 |
Why?
|
Sp1 Transcription Factor | 1 | 1995 | 140 | 0.120 |
Why?
|
Apoptosis | 2 | 2010 | 9466 | 0.120 |
Why?
|
Colon, Ascending | 1 | 2014 | 14 | 0.120 |
Why?
|
Occipital Lobe | 1 | 2016 | 373 | 0.120 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7366 | 0.120 |
Why?
|
Hepatitis B | 2 | 1991 | 701 | 0.120 |
Why?
|
Neoplasm Transplantation | 2 | 2009 | 2013 | 0.120 |
Why?
|
Organogenesis | 1 | 2015 | 215 | 0.120 |
Why?
|
Hedgehog Proteins | 2 | 2010 | 768 | 0.120 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 2 | 2007 | 42 | 0.120 |
Why?
|
Antineoplastic Agents | 5 | 2013 | 13597 | 0.120 |
Why?
|
Retinoblastoma-Like Protein p107 | 1 | 2014 | 71 | 0.120 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2008 | 338 | 0.110 |
Why?
|
Eye Movements | 3 | 2013 | 508 | 0.110 |
Why?
|
DNA Mutational Analysis | 8 | 2007 | 4107 | 0.110 |
Why?
|
Thoracoscopy | 1 | 1994 | 176 | 0.110 |
Why?
|
Retinal Pigment Epithelium | 1 | 2016 | 301 | 0.110 |
Why?
|
Immunomagnetic Separation | 1 | 2013 | 79 | 0.110 |
Why?
|
Blotting, Western | 4 | 2009 | 5031 | 0.110 |
Why?
|
Trans-Activators | 5 | 2019 | 2859 | 0.110 |
Why?
|
Task Performance and Analysis | 1 | 2017 | 759 | 0.110 |
Why?
|
Oligonucleotides, Antisense | 1 | 2016 | 459 | 0.110 |
Why?
|
Automation, Laboratory | 1 | 2013 | 103 | 0.110 |
Why?
|
Risk Assessment | 7 | 2024 | 23816 | 0.110 |
Why?
|
Blinking | 1 | 2013 | 133 | 0.110 |
Why?
|
Internationality | 1 | 2018 | 1000 | 0.110 |
Why?
|
Cell Cycle Proteins | 4 | 2016 | 3434 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2014 | 311 | 0.110 |
Why?
|
Prospective Studies | 10 | 2024 | 54092 | 0.100 |
Why?
|
Optics and Photonics | 1 | 2014 | 304 | 0.100 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 319 | 0.100 |
Why?
|
GTP-Binding Protein beta Subunits | 1 | 2012 | 33 | 0.100 |
Why?
|
Pericardium | 1 | 1997 | 675 | 0.100 |
Why?
|
Injections, Intramuscular | 2 | 1991 | 553 | 0.100 |
Why?
|
Chromosome Segregation | 1 | 2014 | 233 | 0.100 |
Why?
|
Head Movements | 1 | 2013 | 152 | 0.100 |
Why?
|
Enhancer Elements, Genetic | 1 | 2019 | 1356 | 0.100 |
Why?
|
Child | 16 | 2021 | 79782 | 0.100 |
Why?
|
Retinal Bipolar Cells | 1 | 2012 | 46 | 0.100 |
Why?
|
Delayed Diagnosis | 1 | 2016 | 462 | 0.100 |
Why?
|
DNA Replication | 2 | 2014 | 1409 | 0.100 |
Why?
|
Angiopoietin-1 | 2 | 2010 | 122 | 0.100 |
Why?
|
Genes, BRCA2 | 1 | 2015 | 603 | 0.100 |
Why?
|
Autoantibodies | 1 | 2021 | 2116 | 0.100 |
Why?
|
Fusobacterium nucleatum | 1 | 2013 | 165 | 0.100 |
Why?
|
Optic Atrophy, Hereditary, Leber | 2 | 2009 | 50 | 0.100 |
Why?
|
Heart Conduction System | 2 | 2015 | 1011 | 0.100 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2014 | 250 | 0.100 |
Why?
|
Green Fluorescent Proteins | 2 | 2015 | 2056 | 0.100 |
Why?
|
Chromones | 1 | 2012 | 148 | 0.100 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2012 | 489 | 0.100 |
Why?
|
von Hippel-Lindau Disease | 2 | 2007 | 151 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3614 | 0.100 |
Why?
|
Models, Cardiovascular | 1 | 1997 | 970 | 0.100 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2020 | 2267 | 0.100 |
Why?
|
Disease Progression | 7 | 2019 | 13463 | 0.100 |
Why?
|
Microphthalmos | 2 | 2015 | 58 | 0.100 |
Why?
|
HeLa Cells | 4 | 2013 | 3096 | 0.100 |
Why?
|
Bacteriophages | 1 | 2015 | 372 | 0.100 |
Why?
|
Microsatellite Repeats | 3 | 2005 | 785 | 0.100 |
Why?
|
RNA, Messenger | 8 | 2010 | 12761 | 0.100 |
Why?
|
Cytokines | 4 | 2021 | 7336 | 0.100 |
Why?
|
Esophageal Neoplasms | 2 | 2019 | 1647 | 0.100 |
Why?
|
Myelin Proteins | 1 | 2012 | 209 | 0.100 |
Why?
|
Cell Nucleus | 2 | 2014 | 2903 | 0.090 |
Why?
|
Neoplasms | 4 | 2023 | 21986 | 0.090 |
Why?
|
Cytoskeletal Proteins | 3 | 2016 | 1342 | 0.090 |
Why?
|
Nerve Tissue Proteins | 3 | 2021 | 4407 | 0.090 |
Why?
|
Gene Silencing | 2 | 2007 | 1507 | 0.090 |
Why?
|
Ovarian Neoplasms | 2 | 2024 | 4872 | 0.090 |
Why?
|
Microwaves | 1 | 2012 | 185 | 0.090 |
Why?
|
beta Catenin | 3 | 2013 | 1043 | 0.090 |
Why?
|
Child, Preschool | 7 | 2021 | 42045 | 0.090 |
Why?
|
Bacteroidetes | 2 | 2021 | 84 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3809 | 0.090 |
Why?
|
GTP Phosphohydrolases | 1 | 2014 | 516 | 0.090 |
Why?
|
Colitis | 1 | 2019 | 1229 | 0.090 |
Why?
|
Esophagectomy | 1 | 1994 | 465 | 0.090 |
Why?
|
Cathepsin B | 1 | 2010 | 80 | 0.090 |
Why?
|
Diagnosis, Differential | 6 | 2019 | 12951 | 0.090 |
Why?
|
Chemokine CXCL12 | 2 | 2009 | 454 | 0.090 |
Why?
|
Blood Glucose | 1 | 2005 | 6349 | 0.090 |
Why?
|
Cross-Sectional Studies | 9 | 2020 | 25924 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2020 | 3970 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2014 | 2868 | 0.090 |
Why?
|
Computers | 2 | 2023 | 596 | 0.090 |
Why?
|
Chemokine CXCL6 | 1 | 2009 | 14 | 0.090 |
Why?
|
Flavonoids | 2 | 2012 | 444 | 0.090 |
Why?
|
Phenotype | 7 | 2016 | 16533 | 0.090 |
Why?
|
Primary Health Care | 2 | 2016 | 4652 | 0.090 |
Why?
|
Endoscopy | 1 | 2020 | 1832 | 0.090 |
Why?
|
Oncogene Proteins | 1 | 2014 | 719 | 0.080 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 896 | 0.080 |
Why?
|
Follow-Up Studies | 8 | 2021 | 39020 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2016 | 10749 | 0.080 |
Why?
|
Abdominal Pain | 1 | 2016 | 1064 | 0.080 |
Why?
|
Neuropilin-1 | 1 | 2009 | 90 | 0.080 |
Why?
|
Dogs | 4 | 2022 | 3838 | 0.080 |
Why?
|
Microscopy, Fluorescence | 2 | 2015 | 2646 | 0.080 |
Why?
|
Antibodies, Monoclonal | 6 | 2010 | 9163 | 0.080 |
Why?
|
Cell Dedifferentiation | 1 | 2009 | 122 | 0.080 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2013 | 433 | 0.080 |
Why?
|
Hepatitis D | 1 | 1988 | 23 | 0.080 |
Why?
|
Gene Expression | 5 | 2014 | 7584 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 2 | 2007 | 2800 | 0.080 |
Why?
|
Morpholines | 1 | 2012 | 580 | 0.080 |
Why?
|
Treatment Outcome | 13 | 2021 | 64242 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 1133 | 0.080 |
Why?
|
DNA, Complementary | 4 | 2022 | 1992 | 0.080 |
Why?
|
Breast Neoplasms | 2 | 2024 | 20992 | 0.080 |
Why?
|
DNA Helicases | 1 | 2014 | 852 | 0.080 |
Why?
|
Immunoenzyme Techniques | 2 | 2009 | 1704 | 0.080 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2009 | 301 | 0.080 |
Why?
|
Synapses | 2 | 2021 | 1757 | 0.080 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2009 | 436 | 0.080 |
Why?
|
Microfluidics | 1 | 2013 | 652 | 0.080 |
Why?
|
Antigens, Neoplasm | 1 | 2016 | 1994 | 0.080 |
Why?
|
RNA Interference | 1 | 2016 | 2834 | 0.080 |
Why?
|
Sulfonamides | 2 | 2009 | 1972 | 0.070 |
Why?
|
Iatrogenic Disease | 1 | 1991 | 538 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2013 | 3573 | 0.070 |
Why?
|
Risk Factors | 15 | 2021 | 73708 | 0.070 |
Why?
|
Enzyme Inhibitors | 3 | 2012 | 3709 | 0.070 |
Why?
|
Sequence Analysis, DNA | 3 | 2014 | 4710 | 0.070 |
Why?
|
Extracellular Matrix | 3 | 2021 | 1722 | 0.070 |
Why?
|
Epigenesis, Genetic | 2 | 2019 | 3752 | 0.070 |
Why?
|
Stem Cells | 4 | 2014 | 3521 | 0.070 |
Why?
|
Polymers | 1 | 2015 | 1612 | 0.070 |
Why?
|
Adenoma, Villous | 2 | 2005 | 14 | 0.070 |
Why?
|
Umbilical Veins | 1 | 2008 | 426 | 0.070 |
Why?
|
Death, Sudden, Cardiac | 1 | 2015 | 1553 | 0.070 |
Why?
|
Pyrazoles | 2 | 2009 | 1992 | 0.070 |
Why?
|
Anesthesia, General | 1 | 1994 | 1165 | 0.070 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2007 | 40 | 0.070 |
Why?
|
Heartburn | 1 | 2007 | 68 | 0.070 |
Why?
|
Prevalence | 6 | 2020 | 15640 | 0.070 |
Why?
|
Catheter Ablation | 2 | 2012 | 2741 | 0.070 |
Why?
|
Respiration | 3 | 2007 | 1654 | 0.070 |
Why?
|
Neoplasm Invasiveness | 2 | 2009 | 3591 | 0.070 |
Why?
|
Vesicular Transport Proteins | 1 | 2010 | 374 | 0.070 |
Why?
|
Disease Models, Animal | 6 | 2024 | 18114 | 0.070 |
Why?
|
Carcinoma in Situ | 1 | 2012 | 793 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2020 | 3579 | 0.070 |
Why?
|
Transcription Factor AP-1 | 1 | 2008 | 321 | 0.070 |
Why?
|
Founder Effect | 1 | 2007 | 186 | 0.070 |
Why?
|
Incidence | 3 | 2022 | 21217 | 0.070 |
Why?
|
Aneuploidy | 1 | 2010 | 550 | 0.070 |
Why?
|
Medical Oncology | 1 | 2018 | 2308 | 0.070 |
Why?
|
Penetrance | 2 | 2024 | 388 | 0.070 |
Why?
|
Dyspepsia | 1 | 2007 | 116 | 0.070 |
Why?
|
Models, Biological | 3 | 2007 | 9459 | 0.070 |
Why?
|
Contracture | 1 | 1989 | 235 | 0.070 |
Why?
|
Models, Theoretical | 2 | 2015 | 3560 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3309 | 0.070 |
Why?
|
Hydrogen Peroxide | 2 | 2010 | 728 | 0.070 |
Why?
|
Intestinal Polyps | 2 | 2005 | 104 | 0.070 |
Why?
|
Cell Line | 6 | 2014 | 15587 | 0.070 |
Why?
|
Liver Neoplasms | 3 | 2009 | 4314 | 0.070 |
Why?
|
Natural Language Processing | 1 | 2015 | 1135 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2016 | 2212 | 0.070 |
Why?
|
Pancreaticoduodenectomy | 1 | 2009 | 508 | 0.060 |
Why?
|
Insulinoma | 2 | 1997 | 121 | 0.060 |
Why?
|
Polymorphism, Genetic | 4 | 2010 | 4282 | 0.060 |
Why?
|
Genomics | 2 | 2014 | 5788 | 0.060 |
Why?
|
Renin-Angiotensin System | 1 | 2010 | 733 | 0.060 |
Why?
|
HT29 Cells | 1 | 2005 | 190 | 0.060 |
Why?
|
Genome | 1 | 2014 | 1739 | 0.060 |
Why?
|
Intestinal Polyposis | 1 | 2005 | 42 | 0.060 |
Why?
|
Cell Cycle | 3 | 2013 | 2929 | 0.060 |
Why?
|
Endocrine Gland Neoplasms | 1 | 2005 | 23 | 0.060 |
Why?
|
Bone Marrow Transplantation | 2 | 2010 | 2691 | 0.060 |
Why?
|
Neoadjuvant Therapy | 4 | 2011 | 2809 | 0.060 |
Why?
|
HEK293 Cells | 1 | 2015 | 4257 | 0.060 |
Why?
|
Adenoviridae | 1 | 2009 | 1084 | 0.060 |
Why?
|
Nucleic Acid Hybridization | 1 | 2007 | 1304 | 0.060 |
Why?
|
Lens Diseases | 1 | 2005 | 13 | 0.060 |
Why?
|
Gastric Mucosa | 3 | 2014 | 600 | 0.060 |
Why?
|
RNA, Neoplasm | 1 | 2008 | 749 | 0.060 |
Why?
|
Lens Capsule, Crystalline | 1 | 2005 | 39 | 0.060 |
Why?
|
TCF Transcription Factors | 1 | 2005 | 138 | 0.060 |
Why?
|
Chromosomes, Human | 1 | 2007 | 442 | 0.060 |
Why?
|
DNA | 4 | 2014 | 7200 | 0.060 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2005 | 152 | 0.060 |
Why?
|
SEER Program | 3 | 2017 | 1454 | 0.060 |
Why?
|
Receptors, CXCR4 | 1 | 2009 | 727 | 0.060 |
Why?
|
Amniotic Fluid | 1 | 2007 | 378 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 2901 | 0.060 |
Why?
|
Point-of-Care Systems | 1 | 2013 | 1201 | 0.060 |
Why?
|
Ultrasonography, Doppler | 1 | 2007 | 461 | 0.060 |
Why?
|
Sensory Thresholds | 2 | 2019 | 377 | 0.060 |
Why?
|
rho-Associated Kinases | 1 | 2006 | 280 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2017 | 20037 | 0.060 |
Why?
|
Chromosomes, Human, X | 1 | 2006 | 321 | 0.060 |
Why?
|
Barrett Esophagus | 1 | 2008 | 490 | 0.060 |
Why?
|
Transcription, Genetic | 3 | 2012 | 7588 | 0.060 |
Why?
|
Genes, Neoplasm | 1 | 2006 | 370 | 0.060 |
Why?
|
Muscles | 1 | 1989 | 1575 | 0.060 |
Why?
|
Lentivirus | 1 | 2007 | 503 | 0.060 |
Why?
|
Ophthalmoscopy | 3 | 2014 | 171 | 0.060 |
Why?
|
Smad4 Protein | 2 | 2005 | 191 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2016 | 5253 | 0.060 |
Why?
|
RNA | 1 | 2014 | 2716 | 0.060 |
Why?
|
Fetal Blood | 2 | 2005 | 1342 | 0.060 |
Why?
|
Color | 1 | 2005 | 298 | 0.060 |
Why?
|
Transforming Growth Factor beta | 2 | 2002 | 1956 | 0.060 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2005 | 141 | 0.060 |
Why?
|
Gastric Fundus | 2 | 2014 | 37 | 0.060 |
Why?
|
Fluorescein Angiography | 2 | 2022 | 1043 | 0.060 |
Why?
|
Visual Cortex | 1 | 2011 | 1089 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 1998 | 3152 | 0.050 |
Why?
|
Radiotherapy Dosage | 2 | 2007 | 2894 | 0.050 |
Why?
|
Informed Consent | 1 | 2010 | 1003 | 0.050 |
Why?
|
Corneal Opacity | 1 | 2003 | 47 | 0.050 |
Why?
|
Cohort Studies | 8 | 2021 | 41190 | 0.050 |
Why?
|
Reperfusion Injury | 1 | 2010 | 1023 | 0.050 |
Why?
|
Serpins | 1 | 2004 | 247 | 0.050 |
Why?
|
Exotropia | 1 | 2003 | 64 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2024 | 8981 | 0.050 |
Why?
|
Embryo, Mammalian | 2 | 2007 | 1674 | 0.050 |
Why?
|
Prognosis | 9 | 2015 | 29488 | 0.050 |
Why?
|
Descemet Membrane | 1 | 2003 | 71 | 0.050 |
Why?
|
MAP Kinase Signaling System | 1 | 2010 | 1477 | 0.050 |
Why?
|
Survival Analysis | 3 | 2017 | 10075 | 0.050 |
Why?
|
Retinitis Pigmentosa | 1 | 2006 | 397 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2021 | 22022 | 0.050 |
Why?
|
Base Sequence | 4 | 2006 | 12437 | 0.050 |
Why?
|
Alleles | 3 | 1998 | 6894 | 0.050 |
Why?
|
Blepharoptosis | 1 | 2003 | 143 | 0.050 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2006 | 378 | 0.050 |
Why?
|
Biopsy, Fine-Needle | 1 | 2007 | 1110 | 0.050 |
Why?
|
Bone Marrow Cells | 1 | 2010 | 2411 | 0.050 |
Why?
|
PPAR gamma | 1 | 2005 | 481 | 0.050 |
Why?
|
Neoplastic Stem Cells | 1 | 2010 | 1346 | 0.050 |
Why?
|
Iris | 1 | 2003 | 231 | 0.050 |
Why?
|
Cell Adhesion | 2 | 1990 | 3087 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 1926 | 0.050 |
Why?
|
Disclosure | 1 | 2008 | 743 | 0.050 |
Why?
|
Membrane Proteins | 3 | 2014 | 7840 | 0.050 |
Why?
|
Genetic Diseases, Inborn | 1 | 2007 | 601 | 0.050 |
Why?
|
Oxidative Stress | 2 | 2010 | 3102 | 0.050 |
Why?
|
CA-19-9 Antigen | 1 | 2022 | 106 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2008 | 2419 | 0.050 |
Why?
|
Rectum | 1 | 2006 | 891 | 0.050 |
Why?
|
Glucose Tolerance Test | 1 | 2005 | 1173 | 0.050 |
Why?
|
Nerve Growth Factors | 1 | 2004 | 562 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2013 | 21990 | 0.050 |
Why?
|
Fibrosis | 3 | 2021 | 2038 | 0.050 |
Why?
|
Survival Rate | 4 | 2008 | 12684 | 0.050 |
Why?
|
Sex Distribution | 1 | 2007 | 2278 | 0.050 |
Why?
|
Biopsy, Needle | 1 | 2007 | 1627 | 0.050 |
Why?
|
Adaptor Protein Complex 2 | 1 | 2021 | 42 | 0.050 |
Why?
|
CDC2-CDC28 Kinases | 1 | 2001 | 110 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 4 | 2024 | 36270 | 0.050 |
Why?
|
Thyroidectomy | 1 | 2007 | 902 | 0.050 |
Why?
|
Multiple Endocrine Neoplasia | 1 | 2000 | 25 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3432 | 0.050 |
Why?
|
Age Distribution | 1 | 2007 | 2877 | 0.050 |
Why?
|
Wakefulness | 1 | 1988 | 1256 | 0.050 |
Why?
|
Eye Abnormalities | 1 | 2003 | 241 | 0.050 |
Why?
|
Actinobacteria | 1 | 2021 | 56 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 4350 | 0.050 |
Why?
|
Exercise | 1 | 2017 | 5788 | 0.050 |
Why?
|
Molecular Sequence Data | 4 | 2006 | 17615 | 0.050 |
Why?
|
Dynamins | 1 | 2021 | 138 | 0.050 |
Why?
|
CA1 Region, Hippocampal | 1 | 2021 | 110 | 0.050 |
Why?
|
United States | 8 | 2018 | 71902 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2018 | 11709 | 0.040 |
Why?
|
Genes, Regulator | 1 | 2001 | 374 | 0.040 |
Why?
|
Pigment Epithelium of Eye | 2 | 2002 | 209 | 0.040 |
Why?
|
Decision Making | 2 | 2024 | 3909 | 0.040 |
Why?
|
Cataract | 1 | 2006 | 827 | 0.040 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2001 | 747 | 0.040 |
Why?
|
Androstadienes | 1 | 2001 | 348 | 0.040 |
Why?
|
Sleep Apnea Syndromes | 1 | 1988 | 973 | 0.040 |
Why?
|
Graft Survival | 1 | 2010 | 3794 | 0.040 |
Why?
|
Veratrum Alkaloids | 2 | 2010 | 23 | 0.040 |
Why?
|
Disease Management | 1 | 2010 | 2495 | 0.040 |
Why?
|
Oculomotor Muscles | 1 | 2003 | 407 | 0.040 |
Why?
|
Oxygen | 3 | 2010 | 4190 | 0.040 |
Why?
|
Anesthesia, Local | 1 | 2001 | 276 | 0.040 |
Why?
|
Ion Channel Gating | 1 | 2021 | 435 | 0.040 |
Why?
|
Neoplasm Staging | 3 | 2010 | 11082 | 0.040 |
Why?
|
Patient Selection | 1 | 2011 | 4235 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2010 | 3021 | 0.040 |
Why?
|
Retinal Vessels | 1 | 2004 | 836 | 0.040 |
Why?
|
Pyramidal Cells | 1 | 2021 | 368 | 0.040 |
Why?
|
Immunochemistry | 1 | 2018 | 119 | 0.040 |
Why?
|
Jews | 1 | 2000 | 364 | 0.040 |
Why?
|
Radiography | 2 | 2006 | 6956 | 0.040 |
Why?
|
Septins | 1 | 2018 | 49 | 0.040 |
Why?
|
Endothelium, Vascular | 2 | 2008 | 4427 | 0.040 |
Why?
|
Lidocaine | 1 | 2001 | 537 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2002 | 829 | 0.040 |
Why?
|
Gastrinoma | 1 | 1997 | 20 | 0.040 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2001 | 654 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2007 | 2564 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2005 | 1651 | 0.040 |
Why?
|
Mice, Knockout | 4 | 2015 | 14345 | 0.040 |
Why?
|
Cell Movement | 1 | 2009 | 5196 | 0.040 |
Why?
|
Hypoglycemia | 1 | 2005 | 881 | 0.040 |
Why?
|
Taiwan | 2 | 1989 | 504 | 0.040 |
Why?
|
Laminin | 2 | 1990 | 405 | 0.040 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 1998 | 346 | 0.040 |
Why?
|
Models, Genetic | 2 | 2005 | 3441 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2012 | 9514 | 0.040 |
Why?
|
Lung Neoplasms | 3 | 2012 | 13268 | 0.040 |
Why?
|
Serine | 1 | 2021 | 828 | 0.040 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 1998 | 410 | 0.040 |
Why?
|
Vision, Low | 1 | 2019 | 163 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2024 | 2190 | 0.040 |
Why?
|
Genetics | 1 | 2017 | 114 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 1988 | 4886 | 0.040 |
Why?
|
Organoplatinum Compounds | 1 | 2018 | 406 | 0.040 |
Why?
|
Endocytosis | 1 | 2021 | 958 | 0.030 |
Why?
|
Age Factors | 5 | 2018 | 18326 | 0.030 |
Why?
|
Family | 1 | 2008 | 3188 | 0.030 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 1998 | 342 | 0.030 |
Why?
|
Blotting, Southern | 1 | 1997 | 777 | 0.030 |
Why?
|
Safety | 2 | 2013 | 1147 | 0.030 |
Why?
|
Leucovorin | 1 | 2018 | 642 | 0.030 |
Why?
|
Species Specificity | 1 | 2021 | 2413 | 0.030 |
Why?
|
Double-Blind Method | 3 | 2020 | 12261 | 0.030 |
Why?
|
Interneurons | 1 | 2021 | 591 | 0.030 |
Why?
|
Metagenomics | 1 | 2020 | 457 | 0.030 |
Why?
|
Infant | 1 | 2018 | 36045 | 0.030 |
Why?
|
Ornithine-Oxo-Acid Transaminase | 1 | 1996 | 49 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12047 | 0.030 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1997 | 763 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1995 | 777 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 1005 | 0.030 |
Why?
|
Prostaglandins | 1 | 2017 | 398 | 0.030 |
Why?
|
Diet | 2 | 2020 | 8001 | 0.030 |
Why?
|
Blood Volume | 1 | 1997 | 548 | 0.030 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 1997 | 304 | 0.030 |
Why?
|
Lod Score | 2 | 2006 | 602 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2001 | 909 | 0.030 |
Why?
|
Photic Stimulation | 2 | 2012 | 1967 | 0.030 |
Why?
|
Urban Health Services | 1 | 2016 | 176 | 0.030 |
Why?
|
Nervous System Diseases | 1 | 2006 | 1649 | 0.030 |
Why?
|
Fibronectins | 2 | 1990 | 722 | 0.030 |
Why?
|
Injections | 2 | 2009 | 829 | 0.030 |
Why?
|
Thymine | 1 | 1995 | 68 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 2010 | 4214 | 0.030 |
Why?
|
Obesity | 1 | 2017 | 12870 | 0.030 |
Why?
|
Macular Degeneration | 1 | 2002 | 1001 | 0.030 |
Why?
|
Cellular Structures | 1 | 2014 | 9 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2016 | 211 | 0.030 |
Why?
|
Intussusception | 1 | 2016 | 115 | 0.030 |
Why?
|
Ophthalmoscopes | 1 | 2014 | 21 | 0.030 |
Why?
|
Fibroblasts | 1 | 2005 | 4087 | 0.030 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2016 | 200 | 0.030 |
Why?
|
Fruit | 1 | 2020 | 1158 | 0.030 |
Why?
|
Markov Chains | 2 | 2009 | 965 | 0.030 |
Why?
|
Retreatment | 1 | 2016 | 596 | 0.030 |
Why?
|
Anesthetics, Local | 1 | 2001 | 998 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2008 | 15207 | 0.030 |
Why?
|
Insufflation | 1 | 1994 | 61 | 0.030 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2016 | 219 | 0.030 |
Why?
|
Kidney | 1 | 2010 | 7012 | 0.030 |
Why?
|
Cloning, Molecular | 2 | 1997 | 4170 | 0.030 |
Why?
|
Adenoviruses, Human | 1 | 1996 | 255 | 0.030 |
Why?
|
Blood Buffy Coat | 1 | 2013 | 11 | 0.030 |
Why?
|
Gene Order | 1 | 2014 | 169 | 0.030 |
Why?
|
Pressure | 1 | 1997 | 1154 | 0.030 |
Why?
|
Boston | 2 | 2017 | 9298 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 7982 | 0.030 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2014 | 222 | 0.030 |
Why?
|
Centrifugation | 1 | 2013 | 122 | 0.030 |
Why?
|
Pleural Diseases | 1 | 1994 | 137 | 0.030 |
Why?
|
Tissue Adhesions | 1 | 1994 | 218 | 0.030 |
Why?
|
Fetal Monitoring | 1 | 1993 | 69 | 0.030 |
Why?
|
Rats | 3 | 2021 | 23676 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2008 | 11469 | 0.030 |
Why?
|
Telomere | 1 | 2019 | 931 | 0.030 |
Why?
|
Fundus Oculi | 1 | 2014 | 541 | 0.030 |
Why?
|
HL-60 Cells | 1 | 2013 | 363 | 0.030 |
Why?
|
Consanguinity | 2 | 2006 | 456 | 0.030 |
Why?
|
Dissection | 1 | 1994 | 297 | 0.030 |
Why?
|
Biomedical Research | 1 | 2008 | 3415 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2001 | 4019 | 0.030 |
Why?
|
Cardia | 1 | 2012 | 59 | 0.030 |
Why?
|
Community Health Centers | 1 | 2016 | 460 | 0.030 |
Why?
|
Thoracotomy | 1 | 1994 | 363 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14473 | 0.030 |
Why?
|
Cells, Cultured | 5 | 2014 | 18936 | 0.030 |
Why?
|
Medical History Taking | 1 | 2016 | 772 | 0.030 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 1 | 2012 | 94 | 0.030 |
Why?
|
Choline O-Acetyltransferase | 1 | 2012 | 155 | 0.020 |
Why?
|
Sleep | 1 | 1988 | 4745 | 0.020 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2006 | 2416 | 0.020 |
Why?
|
Risk | 2 | 2015 | 9590 | 0.020 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2012 | 102 | 0.020 |
Why?
|
Propionates | 1 | 2012 | 182 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2018 | 1722 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2002 | 2913 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2018 | 5483 | 0.020 |
Why?
|
Malpractice | 1 | 2016 | 555 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2014 | 15532 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2017 | 573 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2021 | 6525 | 0.020 |
Why?
|
TRPM Cation Channels | 1 | 2012 | 139 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1155 | 0.020 |
Why?
|
rab GTP-Binding Proteins | 1 | 2013 | 250 | 0.020 |
Why?
|
RNA Splicing | 1 | 2016 | 913 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 3 | 2011 | 3734 | 0.020 |
Why?
|
Spectrometry, Fluorescence | 1 | 2013 | 683 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1995 | 788 | 0.020 |
Why?
|
Aging | 2 | 2005 | 8654 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2014 | 896 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2016 | 891 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1436 | 0.020 |
Why?
|
Mutagenesis | 1 | 1995 | 1233 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2019 | 1878 | 0.020 |
Why?
|
Sensory Deprivation | 1 | 2011 | 106 | 0.020 |
Why?
|
Tumor Burden | 1 | 2017 | 1886 | 0.020 |
Why?
|
Homozygote | 2 | 2006 | 1788 | 0.020 |
Why?
|
Population Surveillance | 2 | 2012 | 2599 | 0.020 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2012 | 195 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 15774 | 0.020 |
Why?
|
Genetic Linkage | 2 | 2006 | 2381 | 0.020 |
Why?
|
Collagen | 2 | 1990 | 2634 | 0.020 |
Why?
|
Lung Diseases | 2 | 2005 | 1908 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2012 | 695 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 1994 | 636 | 0.020 |
Why?
|
Drug Costs | 1 | 2018 | 1179 | 0.020 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2010 | 86 | 0.020 |
Why?
|
Microspheres | 1 | 2013 | 787 | 0.020 |
Why?
|
Cell Lineage | 1 | 2019 | 2532 | 0.020 |
Why?
|
Physical Examination | 1 | 2016 | 1245 | 0.020 |
Why?
|
Haplotypes | 2 | 2007 | 2764 | 0.020 |
Why?
|
Carbon Dioxide | 1 | 1994 | 1143 | 0.020 |
Why?
|
Nystagmus, Physiologic | 1 | 2009 | 29 | 0.020 |
Why?
|
Exons | 1 | 2016 | 2392 | 0.020 |
Why?
|
Angiogenic Proteins | 1 | 2010 | 101 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2012 | 877 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2012 | 931 | 0.020 |
Why?
|
Oximetry | 1 | 1993 | 460 | 0.020 |
Why?
|
Butadienes | 1 | 2010 | 107 | 0.020 |
Why?
|
Biopsy | 2 | 2012 | 6757 | 0.020 |
Why?
|
Oncogenes | 1 | 1995 | 1222 | 0.020 |
Why?
|
Dendrites | 1 | 2012 | 474 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2010 | 384 | 0.020 |
Why?
|
Hip Contracture | 1 | 1989 | 3 | 0.020 |
Why?
|
Adenine | 1 | 1995 | 975 | 0.020 |
Why?
|
Oxidants | 1 | 2010 | 169 | 0.020 |
Why?
|
Genes, Reporter | 2 | 2007 | 1527 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2012 | 474 | 0.020 |
Why?
|
Motor Activity | 1 | 2019 | 2685 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12397 | 0.020 |
Why?
|
Primates | 1 | 2012 | 523 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2010 | 699 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2012 | 1094 | 0.020 |
Why?
|
Nephritis, Interstitial | 1 | 2010 | 154 | 0.020 |
Why?
|
Hepatitis Antibodies | 1 | 1988 | 68 | 0.020 |
Why?
|
Phosphorylation | 3 | 2010 | 8296 | 0.020 |
Why?
|
Epithelium | 2 | 2010 | 1605 | 0.020 |
Why?
|
Dark Adaptation | 1 | 2009 | 221 | 0.020 |
Why?
|
Decision Trees | 1 | 2010 | 504 | 0.020 |
Why?
|
Endoscopes, Gastrointestinal | 1 | 2008 | 45 | 0.020 |
Why?
|
Visual Pathways | 1 | 2012 | 534 | 0.020 |
Why?
|
Fever | 1 | 2016 | 1617 | 0.020 |
Why?
|
Kidney Tubules, Proximal | 1 | 1990 | 382 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1879 | 0.020 |
Why?
|
Permeability | 1 | 2010 | 718 | 0.020 |
Why?
|
Newfoundland and Labrador | 1 | 2007 | 11 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 1994 | 1165 | 0.020 |
Why?
|
Hepatitis B Surface Antigens | 1 | 1988 | 301 | 0.020 |
Why?
|
Protein Transport | 1 | 2013 | 1963 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2012 | 1732 | 0.020 |
Why?
|
Atrioventricular Node | 1 | 1988 | 180 | 0.020 |
Why?
|
Moral Obligations | 1 | 2008 | 93 | 0.020 |
Why?
|
Hysterectomy | 1 | 2012 | 852 | 0.020 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2008 | 295 | 0.020 |
Why?
|
Shoulder | 1 | 1989 | 299 | 0.020 |
Why?
|
Lactose | 1 | 2007 | 95 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 2 | 2013 | 3165 | 0.020 |
Why?
|
Dermis | 1 | 2008 | 202 | 0.020 |
Why?
|
Heparitin Sulfate | 1 | 1988 | 223 | 0.020 |
Why?
|
Serologic Tests | 1 | 1988 | 384 | 0.020 |
Why?
|
Periodicity | 1 | 1988 | 347 | 0.020 |
Why?
|
Intubation, Intratracheal | 1 | 1994 | 1327 | 0.020 |
Why?
|
Equipment Design | 1 | 2014 | 3502 | 0.020 |
Why?
|
Hydrogen | 1 | 2007 | 171 | 0.020 |
Why?
|
Pregnancy | 2 | 2007 | 29712 | 0.020 |
Why?
|
Societies, Medical | 1 | 2018 | 3887 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5856 | 0.020 |
Why?
|
1,2-Dimethylhydrazine | 1 | 2005 | 8 | 0.020 |
Why?
|
Central Nervous System | 1 | 1993 | 1332 | 0.020 |
Why?
|
Azacitidine | 1 | 2007 | 334 | 0.020 |
Why?
|
Cardiovascular Diseases | 2 | 2009 | 15398 | 0.020 |
Why?
|
Somatostatin | 1 | 2008 | 447 | 0.020 |
Why?
|
Gene Library | 2 | 2002 | 1059 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2011 | 1788 | 0.020 |
Why?
|
DNA Damage | 1 | 1995 | 2439 | 0.020 |
Why?
|
Tachycardia | 1 | 1988 | 600 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2013 | 1897 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2009 | 8512 | 0.020 |
Why?
|
Electric Impedance | 1 | 2010 | 754 | 0.020 |
Why?
|
CpG Islands | 1 | 2010 | 1221 | 0.020 |
Why?
|
Proctoscopy | 1 | 2005 | 40 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2006 | 276 | 0.020 |
Why?
|
Lebanon | 1 | 2006 | 245 | 0.020 |
Why?
|
Colonography, Computed Tomographic | 1 | 2007 | 170 | 0.020 |
Why?
|
Leukocytes | 1 | 2013 | 2024 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 2012 | 1112 | 0.020 |
Why?
|
Sleep, REM | 1 | 1988 | 593 | 0.020 |
Why?
|
Epistaxis | 1 | 2005 | 111 | 0.020 |
Why?
|
Logistic Models | 2 | 2010 | 13221 | 0.020 |
Why?
|
Sex Factors | 2 | 1989 | 10495 | 0.020 |
Why?
|
Polymerase Chain Reaction | 3 | 2003 | 6070 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2013 | 2198 | 0.010 |
Why?
|
Nitriles | 1 | 2010 | 950 | 0.010 |
Why?
|
Ki-67 Antigen | 1 | 2007 | 630 | 0.010 |
Why?
|
Africa | 1 | 2007 | 705 | 0.010 |
Why?
|
Communication Barriers | 1 | 2008 | 413 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3670 | 0.010 |
Why?
|
Creatinine | 1 | 2010 | 1892 | 0.010 |
Why?
|
Research Support as Topic | 1 | 2008 | 697 | 0.010 |
Why?
|
Molecular Biology | 1 | 2008 | 580 | 0.010 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2010 | 866 | 0.010 |
Why?
|
Cardiac Pacing, Artificial | 1 | 1988 | 864 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2010 | 3593 | 0.010 |
Why?
|
Cardiomyopathies | 1 | 2015 | 1945 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2008 | 2469 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2008 | 1177 | 0.010 |
Why?
|
Self Efficacy | 1 | 2007 | 630 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 1994 | 2619 | 0.010 |
Why?
|
Crohn Disease | 1 | 2016 | 2275 | 0.010 |
Why?
|
Carcinogens | 1 | 2005 | 451 | 0.010 |
Why?
|
Maximum Tolerated Dose | 1 | 2005 | 877 | 0.010 |
Why?
|
Protein Binding | 1 | 1995 | 9312 | 0.010 |
Why?
|
Catheterization | 1 | 2008 | 1426 | 0.010 |
Why?
|
Interdisciplinary Communication | 1 | 2008 | 931 | 0.010 |
Why?
|
Arteriovenous Malformations | 1 | 2005 | 397 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7796 | 0.010 |
Why?
|
Proteins | 1 | 1997 | 6024 | 0.010 |
Why?
|
Ophthalmoplegia | 1 | 2003 | 168 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2018 | 20499 | 0.010 |
Why?
|
Electrocardiography | 1 | 2015 | 6363 | 0.010 |
Why?
|
Retinal Drusen | 1 | 2002 | 74 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2005 | 1750 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2008 | 2922 | 0.010 |
Why?
|
Smad3 Protein | 1 | 2002 | 166 | 0.010 |
Why?
|
Computer Simulation | 1 | 2015 | 6198 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2005 | 862 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2010 | 3510 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2002 | 814 | 0.010 |
Why?
|
Absorption | 1 | 2001 | 243 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2009 | 2914 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2010 | 2378 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2796 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10135 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2001 | 184 | 0.010 |
Why?
|
Manometry | 1 | 2003 | 453 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2010 | 2131 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6152 | 0.010 |
Why?
|
Decision Support Systems, Clinical | 1 | 2010 | 1159 | 0.010 |
Why?
|
Recovery of Function | 1 | 2011 | 2969 | 0.010 |
Why?
|
Iran | 1 | 2003 | 737 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 2005 | 1387 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2009 | 1740 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 2002 | 564 | 0.010 |
Why?
|
Binding Sites | 1 | 2009 | 6034 | 0.010 |
Why?
|
Growth Inhibitors | 1 | 2001 | 378 | 0.010 |
Why?
|
Optic Disk | 1 | 2004 | 421 | 0.010 |
Why?
|
Health Care Costs | 1 | 2013 | 3234 | 0.010 |
Why?
|
Kinetics | 1 | 1988 | 6371 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2006 | 1474 | 0.010 |
Why?
|
Cell Division | 2 | 2002 | 4459 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2010 | 6807 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6470 | 0.010 |
Why?
|
COS Cells | 1 | 2001 | 1128 | 0.010 |
Why?
|
Cattle | 1 | 2005 | 3846 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1988 | 6230 | 0.010 |
Why?
|
Immunoblotting | 1 | 2002 | 1647 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 1990 | 3705 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2009 | 3206 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2004 | 2674 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 2 | 2010 | 5638 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2008 | 2818 | 0.010 |
Why?
|
Protein Folding | 1 | 2002 | 866 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2004 | 1966 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2006 | 1184 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2007 | 6204 | 0.010 |
Why?
|
Motivation | 1 | 2007 | 1996 | 0.010 |
Why?
|
Smoking | 1 | 1994 | 9036 | 0.010 |
Why?
|
Social Support | 1 | 2007 | 2152 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3799 | 0.010 |
Why?
|
Tyrosine | 1 | 2001 | 1433 | 0.010 |
Why?
|
Liver Diseases | 1 | 2005 | 1296 | 0.010 |
Why?
|
Luciferases | 1 | 1998 | 714 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2009 | 3526 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2006 | 6292 | 0.010 |
Why?
|
Defective Viruses | 1 | 1996 | 89 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 1998 | 640 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2013 | 5382 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2007 | 3602 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2006 | 2082 | 0.010 |
Why?
|
Trachea | 1 | 2001 | 1082 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2001 | 2506 | 0.010 |
Why?
|
Succinate Dehydrogenase | 1 | 1996 | 145 | 0.010 |
Why?
|
Models, Statistical | 1 | 2009 | 5068 | 0.010 |
Why?
|
Pilot Projects | 1 | 2008 | 8550 | 0.010 |
Why?
|
Databases, Factual | 1 | 2010 | 7927 | 0.010 |
Why?
|
Antibodies | 1 | 2002 | 2420 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2007 | 3238 | 0.010 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1996 | 439 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1742 | 0.010 |
Why?
|
Janus Kinase 1 | 1 | 1993 | 107 | 0.010 |
Why?
|
Electroencephalography | 1 | 1988 | 6187 | 0.010 |
Why?
|
DNA Primers | 1 | 1996 | 2816 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1996 | 1170 | 0.010 |
Why?
|
Heymann Nephritis Antigenic Complex | 1 | 1990 | 15 | 0.010 |
Why?
|
Sheep | 1 | 1993 | 1439 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2008 | 15781 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1993 | 2750 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1990 | 2090 | 0.000 |
Why?
|
Quality of Life | 1 | 2009 | 13263 | 0.000 |
Why?
|
Head and Neck Neoplasms | 1 | 2001 | 2881 | 0.000 |
Why?
|
HIV Infections | 1 | 2013 | 17270 | 0.000 |
Why?
|
Brain | 1 | 1993 | 26952 | 0.000 |
Why?
|
Tidal Volume | 1 | 1988 | 487 | 0.000 |
Why?
|
Integrins | 1 | 1990 | 834 | 0.000 |
Why?
|
Sleep Stages | 1 | 1988 | 691 | 0.000 |
Why?
|
Epitopes | 1 | 1990 | 2502 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2003 | 26176 | 0.000 |
Why?
|
Mitochondria | 1 | 1996 | 3583 | 0.000 |
Why?
|
Glycoproteins | 1 | 1990 | 2205 | 0.000 |
Why?
|
Feasibility Studies | 1 | 1993 | 5194 | 0.000 |
Why?
|
Esophagus | 1 | 1988 | 1023 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1993 | 13442 | 0.000 |
Why?
|